Selling a Medical Practice in 2026 — Valuation, Buyers & What to Expect

Medical practice sales are among the most complex transactions in the lower middle market — not because the valuation math is difficult, but because the regulatory, licensure, and payer mix considerations layer onto a standard M&A process in ways that require careful preparation. Physician-owned practices are selling for 1×–4× of collections in 2026, with significant variation by specialty, geography, practice size, and whether a PE-backed physician management organization (PMO) is active in your specialty and market. The practices that achieve the top of that range share a common profile: strong collections with favorable payer mix, a physician team that is not entirely dependent on the selling physician, a clean Medicare and Medicaid compliance history, and a management structure that a buyer can step into without disruption.

This guide is for physicians who own independent practices — primary care, internal medicine, family medicine, and specialty practices — and are considering a sale, affiliation, or partial transaction in the next one to three years. The landscape for physician practice M&A has shifted significantly in the last five years, and understanding the current buyer market is essential for making a well-informed decision.

How Medical Practices Are Valued

Medical practices are most commonly valued as a multiple of collections (gross revenue) rather than EBITDA, which distinguishes them from most other business categories. Collections multiples are used because healthcare revenue is driven by procedure volume, payer rates, and physician productivity — factors that are more directly captured by revenue than by EBITDA, which can be significantly affected by owner compensation decisions. That said, EBITDA is still relevant: buyers will calculate implied EBITDA margins from your collections to understand how efficiently the practice is run. A primary care practice with $2 million in collections and 20% EBITDA margin (after market-rate physician compensation) is valued differently than the same collections with 8% EBITDA margin — even if the collections multiple appears similar at first glance. Before entering a sale process, every physician should have both their collections multiple and their EBITDA picture clearly calculated.

Valuation by Specialty: What the Market Is Paying in 2026

Specialty significantly affects medical practice valuation because different specialties have different payer mix profiles, reimbursement stability, and strategic acquisition demand. Primary care and family medicine practices typically trade at 1.0×–2.0× collections; they are strategically important to health systems and payers but generally have lower margins. Internal medicine and general surgery are in a similar range. Specialty practices with high commercial payer mix and elective or ancillary revenue streams — dermatology, ophthalmology, orthopedics, ENT, and aesthetic medicine — typically command higher multiples, often in the 2.0×–4.0× collections range, because PE-backed consolidators are actively rolling up these specialties at scale. Behavioral health, psychiatry, and addiction medicine practices have seen significant PE activity, with multiples in the 4×–8× EBITDA range for practices with strong recurring revenue. Pain management, physical therapy, and urgent care have their own active buyer markets with distinct multiple profiles.

Who Is Buying Medical Practices in 2026

There are three primary buyer categories for physician practices today. Health systems and hospital networks have historically been the dominant acquirers of primary care practices, using employment agreements and practice purchase structures that provide stability for the physician while expanding the system's primary care footprint. PE-backed physician management organizations (PMOs) are the most active acquirers across specialty categories — Optum (UnitedHealth), Agilon Health, Privia Health, Catalyst Health Group, Gastro Health, Gastroenterology Associates, and dozens of specialty-specific platforms are executing rollup strategies with significant capital backing. Independent super-group practices — large physician-owned groups acquiring smaller practices to build regional density — are the third buyer category, particularly common in surgical and specialty markets. Each buyer type offers a different deal structure, different post-close autonomy, and different long-term implications for the selling physician.

Payer Mix and Why It Drives Valuation

Payer mix is the single most scrutinized variable in medical practice diligence, and for good reason: the revenue per procedure varies dramatically between commercial insurance, Medicare, Medicaid, and self-pay. A practice with 60%+ commercial payer mix is fundamentally more valuable — on a per-revenue-dollar basis — than a practice with 50% Medicaid exposure, because commercial reimbursement rates are significantly higher and more negotiable. Buyers will rebuild your revenue by payer source and calculate blended reimbursement rates, which means you cannot obscure a challenging payer mix with high gross collections. The best thing a selling physician can do with respect to payer mix is to have clean, current data — ideally organized by CPT code, payer, and reimbursement rate — before buyer conversations begin. This preparation shortens diligence and signals professionalism to acquirers.

The Regulatory and Compliance Dimension

Healthcare M&A has regulatory layers that don't exist in most other industries. The Corporate Practice of Medicine doctrine in states like Maryland, Virginia, and North Carolina restricts who can own and operate a medical practice, which affects deal structure in PE transactions. Stark Law and Anti-Kickback Statute compliance are closely reviewed by buyers during diligence — any compensation arrangements with referring physicians, hospitals, or ancillary providers will be examined. HIPAA compliance, credentialing status, and Medicare/Medicaid enrollment records are standard diligence items. And for practices with in-office ancillary services — imaging, lab, physical therapy — the Stark Law implications of those arrangements are a specific diligence focus. These issues are manageable with preparation, but they require healthcare-specialized M&A counsel. For more information on how I work with healthcare practice owners, visit John's healthcare practice brokerage guide.

What a Medical Practice Sale Process Looks Like

Medical practice transactions typically take six to eighteen months from initial engagement to close, longer than most business categories because of the regulatory approvals, credentialing transfers, and payer contract assignments involved. The preparation phase is critical: financial normalization, payer mix analysis, compliance review, and operational documentation typically take eight to twelve weeks when done properly. The buyer process — CIM preparation, buyer outreach, LOI negotiation, diligence, and close — follows a standard M&A timeline with healthcare-specific add-ons: credentialing for joining physicians takes 90–120 days; payer contract assignments require payer notification and sometimes re-credentialing; and state-specific healthcare regulatory approvals add additional timeline. Physician sellers should budget 12 months for a well-run process and negotiate accordingly on post-closing employment agreements, which most buyers will require for 1–3 years post-close.

Medical Practice M&A in the Southeast and Mid-Atlantic

PE-backed physician platform consolidation has been particularly active in the Southeast and Mid-Atlantic. In North Carolina, Raleigh and Charlotte are both strong markets for specialty practice M&A — the population growth and favorable demographics have attracted multiple active PE platforms. Greenville, SC has emerged as a target market for national PMOs looking for density in secondary markets with strong commercial payer populations. Georgia's suburban Atlanta corridors — Alpharetta, Johns Creek, Marietta — are high-priority geographic targets for specialty rollups in dermatology, ophthalmology, and orthopedics. In Maryland and Virginia, the Northern Virginia and DC corridor markets have significant PMO activity, particularly in primary care and behavioral health. I work with physician practice owners across all of these markets and can help you understand what the current buyer landscape looks like for your specific specialty and geography.